Profil
A.
Keith Willard served as Chairman & CEO at Zeneca, Inc. from 1999 to 1999.
He was President & Director at ICI Canada, Inc. from 1993 to 1999.
He also served as an Independent Director at Inhibitex LLC from 2011 to 2012.
Willard received his undergraduate degree from McGill University and another undergraduate degree from Concordia University.
Anciens postes connus de A. Keith Willard
| Sociétés | Poste | Fin |
|---|---|---|
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Directeur/Membre du Conseil | 13/02/2012 |
| ICI Canada, Inc. | President | 01/10/1999 |
| Zeneca, Inc. | Président | 01/01/1999 |
Formation de A. Keith Willard
| Concordia University | Undergraduate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
| ICI Canada, Inc. | |
| Zeneca, Inc. |